January 2024 FDA Recall Trandolapril by Glenmark Pharmaceuticals Inc., Usa
D-0259-2024 - Failed Excipient Specifications

This Class II drug recall was voluntarily initiated by Glenmark Pharmaceuticals Inc., Usa on January 4, 2024 for the product Trandolapril. The FDA reported the reason for recall as failed excipient specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0259-2024

Reason for Recall
Failed Excipient Specifications: OOS for assay of Isopropyl Alcohol
Initiated
01-04-2024
Reported
01-31-2024
Quantity
38,496 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Glenmark Pharmaceuticals Inc., USA
Fluocinolone Acetonide Oil, 0.01% (Ear Drops), package in 1 Oz. (20 mL fill volume) bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd., Village: Kishanpura, Baddi Nalagarh Road, District: Solan, Himachal Pradesh - 173205, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-185-56

Batch or Lot Expiration Information

Lot# : 05220346, 05220369 Exp 1/31/ 2024; 05220582, Exp 2/29/2024; 05220861 Exp 3/31/2024

Affected Packages Involved in this Recall